Tamibarotene and Arsenic Trioxide for Relapsed Acute Promyelocytic Leukemia

NCT00985530 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Supporting agency withdrew funding for study.

Conditions

Acute Promyelocytic Leukemia

Interventions

DRUG: Tamibarotene
DRUG: Arsenic trioxide

Sponsor

Northwestern University

Collaborators

[object Object]
[object Object]